Covid Test from Plus Safety cooperation with public cooperation, CE certificated. Our products are designated by many European governments. Plus Safety has invested in professional COVID test manufacturers, the COVID test kit we provide, SARS-CoV-2 Antigen Rapid Test Kit, the method used is Colloidal Gold Immunochromatography. Our rapid COVID test kit packed in Card-like format has the following advantage: * Non-invasive. Swabbed specimens from the nasopharynx or oropharyngeal; * Rapid, ONLY in 15 minutes can get the result; * Simple Operation. No more devices required; * High accuracy and stability. Gold-labeled SARS-CoV-2 N protein monoclonal antibodies immobilized on the test area, with corresponding antibodies in the quality control area;
The Prevention Kit is a non-powered, non-invasive, single-use only airway clearance device developed for resuscitating a victim with an airway obstruction when current choking protocols have been followed without success. Prevention Kit has a one-way valve that does not allow any air to enter a choking victim on the downward motion. The Prevention Kit comes fully equipped with an adult , a paediatric , and a practice . The duration of the suction is minimal which makes Prevention Kit safe and effective. Prevention Kit is easy to use in an obstructed airway emergency
Blood glucose testing strip designed to eliminate the risk of a false reading by checking each sample twice. one Touch Ultra 100 Test Strips is a brilliant diabetic care product for diabetic patient to examine the blood sugar level on a regular basis and keep a check on it. The pack consists of 50 blood glucose monitoring strips. The Onetouch Ultra 2 is one of the best in class glucometers which makes self-monitoring of blood glucose very easy. OEM Meter Diabetes Sensor Blood Glucose Test Strips Packing:24Sets / CTN CTN Dimension:37X32.5X20.5CM G.W:4.7 KGs N.W:4.2 KGs
DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit Real-Time OneStep RT-PCR based assay system for detection of SARS-CoV-2 [Product Approval] U.S FDA EUA, Health Canada IO, CE-IVD marked The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial infection or co-infection with other viruses. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.